Next Biomedical Co.,Ltd. (KOSDAQ:389650)
South Korea
· Delayed Price · Currency is KRW 46,200
-1,300 (-2.74%)
Last updated: Jun 26, 2025
Next Biomedical Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Cash & Equivalents | 5,830 | 4,950 | 3,902 | 3,014 | 22,016 | 6,740 | Upgrade
|
| Short-Term Investments | 13,133 | 20,766 | 10,388 | 11,783 | - | - | Upgrade
|
| Trading Asset Securities | 22,494 | 15,892 | - | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 41,456 | 41,609 | 14,290 | 14,797 | 22,016 | 6,740 | Upgrade
|
| Cash Growth | 190.11% | 191.17% | -3.43% | -32.79% | 226.66% | -39.94% | Upgrade
|
| Accounts Receivable | 2,133 | 1,845 | 918.64 | 314.3 | 118.67 | 104.03 | Upgrade
|
| Other Receivables | 210.07 | 321.39 | 214.28 | 170.84 | 86.52 | 6.55 | Upgrade
|
| Receivables | 2,343 | 2,167 | 1,133 | 485.15 | 205.19 | 110.58 | Upgrade
|
| Inventory | 2,558 | 2,581 | 2,169 | 1,940 | 1,313 | 1,973 | Upgrade
|
| Prepaid Expenses | 181.46 | 190.08 | 155.85 | 207.32 | 138.44 | 186.68 | Upgrade
|
| Other Current Assets | 293.15 | 341.35 | 220.7 | 90.8 | 65.69 | 304.12 | Upgrade
|
| Total Current Assets | 46,832 | 46,888 | 17,968 | 17,521 | 23,739 | 9,315 | Upgrade
|
| Property, Plant & Equipment | 11,306 | 11,270 | 11,428 | 11,735 | 11,918 | 11,860 | Upgrade
|
| Long-Term Investments | - | - | - | 2,637 | 3,737 | 3,088 | Upgrade
|
| Other Intangible Assets | 318.04 | 344.38 | 217.63 | 222.19 | 288.71 | 288.99 | Upgrade
|
| Long-Term Accounts Receivable | 0 | -0 | -0 | -0 | -0 | 0 | Upgrade
|
| Other Long-Term Assets | 710.66 | 342.75 | 29.48 | 21.35 | 37.51 | 38.82 | Upgrade
|
| Total Assets | 59,167 | 58,844 | 29,643 | 32,136 | 39,720 | 24,591 | Upgrade
|
| Accounts Payable | 138.68 | 13.37 | 58.16 | 45.02 | 4.1 | 9.19 | Upgrade
|
| Accrued Expenses | 146.47 | 126.23 | 121.14 | 106.93 | 96.48 | 91.11 | Upgrade
|
| Short-Term Debt | 5,600 | 5,600 | 5,600 | 5,600 | 5,600 | 4,430 | Upgrade
|
| Current Portion of Long-Term Debt | 4,439 | 4,539 | 4,897 | 4,800 | 5,200 | 5,600 | Upgrade
|
| Current Portion of Leases | 23.42 | 26.37 | 41.51 | 35.6 | 32.24 | 37.92 | Upgrade
|
| Other Current Liabilities | 1,815 | 1,579 | 714.37 | 452.97 | 2,115 | 28,503 | Upgrade
|
| Total Current Liabilities | 12,163 | 11,884 | 11,433 | 11,041 | 13,048 | 38,671 | Upgrade
|
| Long-Term Debt | 721.84 | 763.5 | 933.54 | 500 | 20,873 | 3,456 | Upgrade
|
| Long-Term Leases | 16.25 | 20.58 | 46.9 | 81.63 | 46.55 | 39.96 | Upgrade
|
| Other Long-Term Liabilities | 239.45 | 235.35 | 218.84 | 368.8 | 284.7 | 18,999 | Upgrade
|
| Total Liabilities | 13,862 | 13,653 | 13,191 | 12,462 | 34,636 | 61,457 | Upgrade
|
| Common Stock | 4,044 | 4,043 | 3,174 | 3,110 | 3,105 | 713.29 | Upgrade
|
| Additional Paid-In Capital | 107,302 | 107,234 | 61,632 | 60,679 | 60,603 | 2,499 | Upgrade
|
| Retained Earnings | -70,613 | -70,181 | -72,984 | -65,367 | -59,673 | -43,043 | Upgrade
|
| Comprehensive Income & Other | 4,572 | 4,095 | 2,277 | 1,324 | 1,049 | 724.57 | Upgrade
|
| Total Common Equity | 45,305 | 45,191 | -5,901 | -253.84 | 5,084 | -39,106 | Upgrade
|
| Shareholders' Equity | 45,305 | 45,191 | 16,452 | 19,674 | 5,084 | -36,866 | Upgrade
|
| Total Liabilities & Equity | 59,167 | 58,844 | 29,643 | 32,136 | 39,720 | 24,591 | Upgrade
|
| Total Debt | 10,801 | 10,949 | 11,519 | 11,017 | 31,751 | 13,564 | Upgrade
|
| Net Cash (Debt) | 30,655 | 30,659 | 2,771 | 3,780 | -9,735 | -6,824 | Upgrade
|
| Net Cash Growth | 1006.49% | 1006.61% | -26.70% | - | - | - | Upgrade
|
| Net Cash Per Share | 3914.10 | 4146.00 | 441.28 | 608.67 | -2011.96 | -1594.48 | Upgrade
|
| Filing Date Shares Outstanding | 8.09 | 8.09 | 6.28 | 6.21 | 4.84 | 4.28 | Upgrade
|
| Total Common Shares Outstanding | 8.09 | 8.09 | 6.28 | 6.21 | 4.84 | 4.28 | Upgrade
|
| Working Capital | 34,669 | 35,004 | 6,536 | 6,480 | 10,691 | -29,357 | Upgrade
|
| Book Value Per Share | 5601.40 | 5588.37 | -939.89 | -40.88 | 1050.64 | -9136.87 | Upgrade
|
| Tangible Book Value | 44,987 | 44,847 | -6,119 | -476.03 | 4,795 | -39,395 | Upgrade
|
| Tangible Book Value Per Share | 5562.08 | 5545.78 | -974.55 | -76.65 | 990.97 | -9204.39 | Upgrade
|
| Land | 5,277 | 5,277 | 5,277 | 5,277 | 5,277 | 5,385 | Upgrade
|
| Buildings | 5,786 | 5,786 | 5,786 | 5,786 | 5,786 | 5,044 | Upgrade
|
| Machinery | 1,598 | 1,598 | 1,430 | 1,397 | 1,504 | 1,338 | Upgrade
|
| Construction In Progress | 232.45 | 99.29 | 119.06 | 150.11 | 188.87 | 660.15 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.